发明名称 REMEDY FOR INTERNAL ADMINISTRATION AGAINST CRANIAL NERVE DISEASES CONTAINING MESENCHYMAL CELLS AS THE ACTIVE INGREDIENT
摘要 By collecting bone marrow cells from rat bone marrow and intravenously administering the cells to a brain infarction model rat, it is found out that these cells are efficacious in treating brain infarction. It is also found out that human and mouse bone marrow stem cells have the same effect. Namely, mesenchymal cells such as bone marrow cells, umbilical cord blood cells or peripheral blood cells are usable as a drug for intravenous administration against cranial nerve diseases.
申请公布号 KR20060059914(A) 申请公布日期 2006.06.02
申请号 KR20057025127 申请日期 2004.06.25
申请人 RENOMIDX INSTITUTE INC.;MITSUI SUMITOMO INSURANCE COMPANY, LIMITED;HITACHI, LTD.;ASKA PHARMACEUTICAL CO., LTD. 发明人 HONMOU OSAMU;HAMADA HIROFUMI
分类号 A61K35/28;A61K35/12;A61K35/14;A61K35/34;A61P25/00;A61P25/28;C12N5/0775 主分类号 A61K35/28
代理机构 代理人
主权项
地址